Join our Free Newsletter and unlock 50% off AltIndexFree newsletter + 50% offJoin free

Zymeworks (ZYME) Stock Analysis: AI Score & Alternative Data

Price
$29.63 +3.11%
AI Score
50Hold
Earnings
Nov 9
Market Cap
$2B
PE Ratio
—
52w Range
$16 – $31
$29.63 +3.11% vs prev close
ZYME Stock Price vs. AI Score Data gathered: November 7
3M +25.9%
50/100 AI Score
Hold
Brand
50/100
Employment
54/100
User Growth
67/100
Fundamental
46/100

Today's AI read on ZYME

ZYME alt-data: web traffic climbing, job postings lagging

Is Zymeworks a buy right now? The alternative data says hold. This ZYME stock analysis is built on the 25+ alternative data signals AltIndex tracks on Zymeworks every day — hiring, web traffic, sentiment, social reach — rolled into an AI Score of 50/100: a Hold. The stock trades at $29.63 with a $2B market cap.

The bullish side of the 90-day ledger: web traffic up 16.1% to 41K monthly visits. The drag: job postings down 22.2% to 7 open roles, and just 46% of employees report a positive business outlook. That tension is what keeps the score mid-range.

ZYME’s broader alt-data profile also covers headcount (266 employees, according to LinkedIn), X followers (1K), and Reddit mentions (1 a day). Every signal links to its own page with full history, the ZYME technical analysis covers RSI, moving averages, and support and resistance, and the full table of everything AltIndex tracks on ZYME is just below.

Zymeworks AI Stock Analysis

Zymeworks Inc. is a clinical-stage biopharmaceutical company that is dedicated to the development of therapeutic treatments for cancer. The company leverages its proprietary platform to design antibodies and other protein therapeutics, which are aimed at improving patient outcomes and quality of life.

Analysis generated October 1, 2026.

Read the full ZYME deep-dive
Fundamentals, alt-data signals and the full methodology, refreshed daily.
Read full analysis

Recent Zymeworks Stock Alerts

Zymeworks logo Zymeworks | November 5
Price is down by -6.1% in the last 24h.
Zymeworks logo Zymeworks | October 20
Price is up by 6.1% in the last 24h.
Zymeworks logo Zymeworks | October 11
Insider Alert: Schayowitz Adam is selling shares
Zymeworks logo Zymeworks | August 26
Price is up by 7.3% in the last 24h.
Get ZYME alerts in real-time
The moment Reddit spikes, sentiment flips, or insiders trade.
Try Stock Alerts Free

Zymeworks Alternative Data

Alternative Data Value 3m Change Trend
Webpage Traffic 41K 16.1%
Job Posts 7 22.2%
LinkedIn Employees 266 1.8%
Employee Recommend 51 0%
Business Outlook 46 2.1%
Sentiment 0 100.0%
Reddit Mentions 1 N/A
X Mentions 3 200.0%
Stocktwits Mentions 7 22.2%
News Mentions 0 N/A
Stocktwits Subscribers 3K 1.5%
4chan Mentions 0 N/A
X Followers 1K 0.5%

About Zymeworks (ZYME)

Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.

Zymeworks logo
Price$29.63
Target Price$387.74
Volume63,420,177
Market Cap$2B
Year Range$16 – $31
Dividend Yield0%
PE Ratio—
Analyst Rating38% buy
IndustryBiotechnology

Latest Zymeworks News

View more →

Zymeworks Earnings & Financial Performance

View all earnings →

Zymeworks Insider Trading Activity

View all →
Schayowitz Adam filed to sell 23,205 shares at $0.0.
Oct 9 '26
Moore Paul Andrew filed to sell 48,497 shares at $0.0.
Jan 12 '26
Smith Jeffrey T L filed to sell 26,708 shares at $0.0.
Jan 12 '26
Hollywood Mark filed to sell 132,913 shares at $0.0.
Jan 12 '26
Galbraith Kenneth filed to sell 226,842 shares at $0.0.
Jan 12 '26

Zymeworks Congress Trading

View all →
Politician Filing Date Type Size
No congress trades on file.

Frequently Asked Questions: Zymeworks (ZYME)

Zymeworks has an AltIndex AI Score of 50/100 (Hold). The score reflects mixed alternative data signals. All investments carry risk.

50/100. The AI Score combines 25+ alternative data signals including job postings, employee sentiment, social media, web traffic, and financials. Scores above 60 = buy, 40–59 = hold, below 40 = sell. Updated daily.

Currently, the price of one share of Zymeworks (ZYME) stock is $29.63 with a market cap of $2B.

As of today, Zymeworks’s PE (Price to Earnings) ratio is —.

View the latest Zymeworks insider transactions to see recent buying and selling activity by company executives and directors.

Check the Zymeworks congress trading page for the latest disclosed trades by U.S. senators and representatives.

AltIndex tracks 25+ signals including job postings, web traffic, employee sentiment, Reddit mentions, Stocktwits activity, insider transactions, congressional trades, Google Trends, app downloads, and more.

The ZYME stock price chart above shows Zymeworks’s performance over time alongside its AI Score. Investors can identify patterns, trends, and potential support or resistance levels. View the full Zymeworks technical analysis for RSI, moving averages, and more.

See the stocks similar to Zymeworks section on this page for companies in the same industry ranked by market cap and AI Score.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.